Dr. Sharon E. Orrange, MD

Dr. Orrange practices at K and B Surgical Center, LLC in Beverly Hills, California.

Dr. Orrange's NPI, 1316983406, was assigned on June 20, 2006. Dr. Orrange graduated from Keck School of Medicine of USC in 1998. Dr. Orrange holds California license A70054.

Dr. Orrange's primary practice is K and B Surgical Center, LLC, at 9033 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 858-1242.

Dr. Orrange's primary practice is K and B Surgical Center, LLC in Beverly Hills, California. Dr. Orrange is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Orrange to 2 more group practices and clinics, 1 home health agency, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orrange practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Orrange's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Orrange is board certified in internal medicine by the American Board of Internal Medicine. Dr. Orrange is licensed in California.

Dmand AI lists chronic diabetes, chronic hypertension, chronic kidney disease, coronary artery disease, facial skin infection, fibromyalgia and chronic pain, fluid in a joint and high cholesterol among the conditions Dr. Orrange treats.

CMS data shows 306 Medicare services from Dr. Orrange across 8 procedure codes in 2024, for 55 Medicare patients. Medicare paid $8,216 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Dr. Orrange in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Orrange's median patient age at 65, with 75% women.

In 2024, Dr. Orrange wrote 241 Medicare Part D claims for 44 patients. 85% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $14,806 in total drug cost. In 2023, CMS named 429 claims across 20 drugs.

Dr. Orrange accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orrange as offering telehealth.

Dmand AI links 13 papers to Dr. Orrange, published from 2009 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Information Seeking Behavior, Patient Satisfaction and Physician-Patient Relations. Dr. Orrange has published most often in Patient Educ Couns. Dr. Orrange's most frequent co-authors are Richard L. Kravitz, MD, Anne L. Peters, MD and Julia A. Cassetta, MD.

CMS Open Payments shows 88 general payments to Dr. Orrange from 18 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 97% of the total. Novo Nordisk Inc paid the most, $705.

Dmand AI lists 2 awards for Dr. Orrange, most recently Choi Family Award for Excellence in Patient Centered Care in 2022. Dr. Orrange serves on Keck Student Performance Committee.

Dr. Orrange graduated from Keck School of Medicine of USC in 1998. Dr. Orrange is a member of ACP.

Dr. Orrange is in network with 12 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.